Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.

Cancer research - 1 Dec 2002

Lorenzato Annalisa, Olivero Martina, Patanè Salvatore, Rosso Edoardo, Oliaro Alberto, Comoglio Paolo M, Di Renzo Maria Flavia

Abstract excerpt

Several gene mutations responsible for human cancer initiation have been discovered, whereas only a few have been identified in association with the progression to metastasis. In this study, we screened a large panel of human sporadic cancers, metastases, and tumor cell lines for mutations in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Cell Movement
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Neoplasm Invasiveness

Share to Neoplasms

Share to Proto-Oncogene Proteins c-met

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 12460923

Genes

MET

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12460923-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.PMID 12460923Read ↗

MET in human cancer: germline and somatic mutationsSemantic proximity Read ↗

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.Semantic proximity Read ↗

Recording and classifying MET receptor mutations in cancers.Semantic proximity Read ↗

Activating mutations for the Met tyrosine kinase receptor in human cancerSemantic proximity Read ↗

A mouse model of activating Met mutations.Semantic proximity Read ↗

Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.Semantic proximity Read ↗

The mutationally activated Met receptor mediates motility and metastasisSemantic proximity Read ↗

Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET InhibitorsSemantic proximity Read ↗

Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells.Semantic proximity Read ↗

Novel mutation in the ATP-binding site of theMET oncogene tyrosine kinase in a HPRCC familySemantic proximity Read ↗

Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele.Semantic proximity Read ↗

MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.